- Efficacy: It is effective in preventing and treating thromboembolic events. - Safety: Lower risk of bleeding complications compared to UFH. - Convenience: Subcutaneous administration allows outpatient management and self-administration. - Predictable Response: Requires less frequent monitoring compared to UFH.